Stock MTNB MATINAS BIOPHARMA HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Matinas BioPharma Holdings, Inc.

Equities

MTNB

US5768101058

Market Closed - Nyse
Other stock markets
 04:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
0.165 USD -1.49% Intraday chart for Matinas BioPharma Holdings, Inc. -6.09% -23.68%
May. 09 Transcript : Matinas BioPharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09 Matinas BioPharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MATINAS BIOPHARMA HOLDINGS, INC. Stock Matinas BioPharma Holdings, Inc.
 42.01M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 22.31B -
ARGENX SE Stock argenx SE
 21.6B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 18.23B -
  1. Stock Market
  2. Equities
  3. MTNB Stock
  4. Charts Matinas BioPharma Holdings, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW